Asset Details
Do you wish to reserve the book?
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Do you wish to request the book?
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
2011
Overview
Although in vitro models have been a cornerstone of anti-cancer drug development, their direct applicability to clinical cancer research has been uncertain. Using a state-of-the-art Taqman-based quantitative RT-PCR assay, we investigated the multidrug resistance (MDR) transcriptome of six cancer types, in established cancer cell lines (grown in monolayer, 3D scaffold, or in xenograft) and clinical samples, either containing >75% tumor cells or microdissected. The MDR transcriptome was determined a priori based on an extensive curation of the literature published during the last three decades, which led to the enumeration of 380 genes. No correlation was found between clinical samples and established cancer cell lines. As expected, we found up-regulation of genes that would facilitate survival across all cultured cancer cell lines evaluated. More troubling, however, were data showing that all of the cell lines, grown either in vitro or in vivo, bear more resemblance to each other, regardless of the tissue of origin, than to the clinical samples they are supposed to model. Although cultured cells can be used to study many aspects of cancer biology and response of cells to drugs, this study emphasizes the necessity for new in vitro cancer models and the use of primary tumor models in which gene expression can be manipulated and small molecules tested in a setting that more closely mimics the in vivo cancer microenvironment so as to avoid radical changes in gene expression profiles brought on by extended periods of cell culture.
Publisher
National Academy of Sciences,National Acad Sciences
Subject
Antineoplastic Agents - therapeutic use
/ ATP binding cassette transporters
/ Cancer
/ Drug Screening Assays, Antitumor - methods
/ drugs
/ Female
/ Gene Expression Regulation, Neoplastic
/ genes
/ Humans
/ Ovarian Neoplasms - metabolism
/ Reverse Transcriptase Polymerase Chain Reaction
/ Translational Medical Research - methods
/ Tumor Suppressor Protein p53 - metabolism
/ Tumors
